Legal Representation
Attorney
Leon R. Legleiter
USPTO Deadlines
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 3, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 3, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 28, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 30, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 30, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 30, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 30, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 30, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 28, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 28, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 28, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 30, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 30, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 30, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Apr 2, 2024 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 7, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Dec 20, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Dec 20, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Oct 2, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 2, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 2, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Aug 21, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 15, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 15, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 6, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 15, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 15, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Dec 20, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Dec 19, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 6, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 19, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 15, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 14, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, preparations for the treatment of cancer; medical preparations, namely, preparations for the treatment of cancer; veterinary preparations, namely, preparations for the treatment of cancer; anti-cancer drugs; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; biological preparations for medical purposes, namely, for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of cancer; biotechnological preparations for medical use for the treatment of cancer; chemical preparations for medical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical use, namely, for prevention or treatment of cancer; chemotherapeutics; pharmaceutical compounds for treating cancer; drugs for medical purposes for the treatment of cancer; medicines, namely, medicines for cancer disorders; medicines for human purposes, namely, cancer medicines; pharmaceutical compositions, namely, preparations for the treatment of cancer; pharmaceutical drugs, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, preparations for the treatment of cancer; pharmaceutical preparations for medical purposes, namely, preparations for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer
Classification
International Classes
005